Project Grant HT94252510198
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$578K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
The University of Colorado-Denver received a $1,260,839 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, which runs from May 1, 2025 to April 30, 2029, supports research to target EHMT1/2 in order to overcome therapy-resistant ovarian cancer. The university, a prominent medical research institution, will conduct advanced biomedical investigations focusing on innovative...
The University of Colorado-Denver has been awarded a $1,130,984 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "DEFINING AND TARGETING CHROMOBOX2 (CBX2)-MEDIATED CHEMORESISTANCE IN HIGH GRADE SEROUS CARCINOMA". The grant will support the university's research efforts to investigate novel approaches for overcoming chemoresistance in high-grade serous carcinoma, a form of ovarian cancer, over a...
The University of Colorado Denver was awarded a $466,494 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a research project examining the role of the tumor microbiome in mucosal melanoma development and antitumor immunity. The study aims to transform health care for service members and the public by investigating medical solutions for the battlefield through innovative and impactful biomedical...
The University of Colorado Denver was awarded a $3,067,768 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the mechanisms underlying brain metastatic progression in ER+ breast cancer. The three-year award running from September 1, 2022 to August 31, 2025 will support research into medical solutions for the battlefield by transforming healthcare through innovative and impactful...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
The Regents of the University of Colorado received a $949,216 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2021 to June 30, 2025 to define a novel therapeutic application of lactoferrin for intestinal inflammation. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
This federal Project Grant award in the amount of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver. The grant will fund a 2-year project from July 1, 2024 to June 30, 2026 to investigate the use of cell-free DNA to define MYC activity in osteosarcoma. The University of Colorado-Denver, a major public research institution, will serve as the primary awardee and perform the research...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
The Regents of the University of Colorado received a $2,121,871 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The four-year award will support research defining a novel therapeutic application of lactoferrin for intestinal inflammation from July 1, 2021 to June 30, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
The U.S. Department of the Army Medical Command awarded a $1,363,999 project grant under the Military Medical Research and Development (CFDA 12.420) program to the University of Colorado-Denver. The grant, titled "Living Well with Brain Cancer (LWBC): A Group-Based Intervention to Promote Whole-Person Well-Being," will fund research to develop and evaluate a group-based intervention to improve the overall well-being of individuals living with brain cancer. The University of...